Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

Acetylator Genotype-dependent Expression of Arylamine N-Acetyltransferase in Human Colon Cytosol from Non-Cancer and Colorectal Cancer Patients

Ward G. Kirlin, Fredrick Ogolla, Allen F. Andrews, Alma Trinidad, Ronald J. Ferguson, Tokunbo Yerokun, Mandi Mpezo and David W. Hein
Ward G. Kirlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrick Ogolla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allen F. Andrews
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alma Trinidad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald J. Ferguson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tokunbo Yerokun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mandi Mpezo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W. Hein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published January 1991
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Human epidemiological studies suggest an association between rapid acetylator phenotype and colorectal cancer. Acetylator genotype-dependent expression by the human colon of arylamine N-acetylation capacity, catalyzed by acetyl coenzyme A-dependent N-acetyltransferase(s) (EC 2.3.1.5) (NAT), may be an important risk factor in the initiation of colorectal cancer. Human colon cytosols from 48 fresh surgical samples were investigated for NAT activity toward p-aminobenzoic acid and the arylamine carcinogens 4-aminobiphenyl, 2-aminofluorene, and β-naphthylamine. Apparent Vmax determinations of NAT activity toward these substrates indicated that 40 of these colons segregated into 3 distinct phenotypes. The distribution of the patients into rapid (5), intermediate (18), or slow (17) acetylators is a ratio that is not significantly different from the expected Hardy-Weinberg distribution of 3:16:21 (χ2 = 2.206, P = 0.363). Significantly greater mean apparent Vmax levels were found in colons from rapid as compared to intermediate acetylators (1.5-3-fold) (P < 0.001) and intermediate as compared to slow (2.5–3-fold) (P < 0.005) acetylator phenotypes for the four arylamine substrates. Apparent Km determinations indicated that human colon NAT from rapid acetylators had a significantly lower affinity for the arylamine substrates (P < 0.05) compared to intermediate or slow acetylator groups. No difference in apparent Km was detected for the cofactor acetyl coenzyme A between the three acetylator phenotypes. The colon samples were also tested for cytosolic N-hydroxy-2-acetylaminofluorene sulfotransferase activity and found to be monomorphically distributed for this enzyme activity. Of the 40 colon samples, 37 were from individuals of known pathology, 25 with colorectal cancer and 12 with no diagnosed neoplasia. Comparisons between mean apparent Vmax and mean apparent Km levels for each of the acetylator phenotypes indicated no significant differences between non-cancer and colorectal cancer patients. The distribution of rapid, intermediate, and slow acetylator phenotypes among the colon samples derived from colorectal cancer patients was precisely that predicted from published frequencies for the rapid and slow acetylator allele in Americans of African and European ancestry.

Footnotes

  • ↵1 This work was supported in part by USPHS Grants CA-34627 and RR-08248 from the NIH/National Cancer Institute. Preliminary reports of this work were presented to the 1989 Annual Meeting of the American Association for Cancer Research, San Francisco, CA (26).

  • ↵2 To whom requests for reprints should be addressed, at Department of Pharmacology, Morehouse School of Medicine, 720 Westview Dr., S. W., Atlanta, GA 30310-1495.

  • ↵4 Medical student at Meharry Medical College, Nashville, TN.

  • ↵6 Graduate student in molecular genetics at Georgia State University, Atlanta, GA.

  • ↵7 Supported by NIH Grant RR-08248 during doctoral studies in Biology at Clark Atlanta University, Atlanta, GA. Present address: Biochemical Pharmacology Section, Samuel Roberts Nobel Foundation, Ardmore, OK 73402.

  • ↵8 Graduate student in Biology at Clark Atlanta University. Supported by NIH Grant RR-08248.

  • Received June 4, 1990.
  • Accepted November 1, 1990.
  • ©1991 American Association for Cancer Research.
PreviousNext
Back to top
January 1991
Volume 51, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Acetylator Genotype-dependent Expression of Arylamine N-Acetyltransferase in Human Colon Cytosol from Non-Cancer and Colorectal Cancer Patients
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Acetylator Genotype-dependent Expression of Arylamine N-Acetyltransferase in Human Colon Cytosol from Non-Cancer and Colorectal Cancer Patients
Ward G. Kirlin, Fredrick Ogolla, Allen F. Andrews, Alma Trinidad, Ronald J. Ferguson, Tokunbo Yerokun, Mandi Mpezo and David W. Hein
Cancer Res January 15 1991 (51) (2) 549-555;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Acetylator Genotype-dependent Expression of Arylamine N-Acetyltransferase in Human Colon Cytosol from Non-Cancer and Colorectal Cancer Patients
Ward G. Kirlin, Fredrick Ogolla, Allen F. Andrews, Alma Trinidad, Ronald J. Ferguson, Tokunbo Yerokun, Mandi Mpezo and David W. Hein
Cancer Res January 15 1991 (51) (2) 549-555;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Genetic Control of Programmed Cell Death in the Nematode Caenorhabditis elegans
  • Role of TCL1 and ALL1 in Human Leukemias and Development
  • The Prizes
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement